RNU6-731P

Across TCGA pan-cancer cohorts, RNU6-731P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RNU6-731P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-731P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-731P expression acts as an unfavorable survival marker, although some lineages such as STAD and CHOL show a favorable association.

STAD, MESO, and KIRC are the cancer types where RNU6-731P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.726	0.523	.001	63	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	54	view →
KIRC	DFS	Tertile	All	0.405	0.706	.001	45	view →
COAD	DFS	Tertile	III,IV	0.134	0.452	.005	39	view →
CHOL	DFS	Tertile	All	1.000	0.329	.020	24	view →
BLCA	OS	Tertile	IV	0.679	0.414	.011	21	view →
PAAD	DFS	Tertile	II,III,IV	0.205	0.461	.003	18	view →
ACC	DFS	Tertile	II,III,IV	0.194	0.617	.005	18	view →
LAML	DFS	Tertile	All	0.405	0.202	.009	16	view →
THCA	OS	Tertile	II,III,IV	0.907	0.977	.012	12	view →
READ	OS	Tertile	II,III,IV	0.889	0.578	.045	12	view →
DLBC	OS	Tertile	IV	0.147	1.000	.045	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RNU6-731P–STAD (OS)

Open the STAD breakdown →